-
Mar 18, 2021 02:00 PM IST Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9600 in its research report dated March 17, 2021.
-
Feb 26, 2021 01:02 PM IST ICICI Direct is bullish on Sanofi India recommended buy rating on the stock with a target price of Rs 9820 in its research report dated February 24, 2021.
-
Feb 26, 2021 10:11 AM IST -
Feb 25, 2021 10:00 AM IST -
Feb 24, 2021 01:28 PM IST Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9249 in its research report dated February 23, 2021.
-
Feb 24, 2021 10:55 AM IST -
Nov 02, 2020 03:04 PM IST Sharekhan is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 9249 in its research report dated October 27, 2020.
-
Oct 30, 2020 04:27 PM IST ICICI Direct is bullish on Sanofi India recommended buy rating on the stock with a target price of Rs 9820 in its research report dated October 28, 2020.
-
Oct 29, 2020 09:44 AM IST -
Oct 27, 2020 07:08 PM IST The company had posted a net profit of Rs 126.6 crore in the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
-
Oct 27, 2020 06:33 PM IST -
Aug 03, 2020 11:39 AM IST ICICI Direct is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 8815 in its research report dated July 29, 2020.
-
Jul 29, 2020 09:45 AM IST -
Jul 28, 2020 07:00 PM IST The company had posted a net profit of Rs 97.4 crore for the corresponding period of the previous fiscal, Sanofi India said in a BSE filing.
-
May 19, 2020 08:18 PM IST Revenue from operations of the company stood at Rs 784.5 crore for the quarter under consideration. It was Rs 717.3 crore for the same period a year ago, it added.
-
Feb 26, 2020 10:17 AM IST The company's profit for the period jumped 22.7 percent year-on-year (YoY), coming at Rs 97.3 crore in Q4CY19 against Rs 79.3 crore in Q4CY18.
-
Jul 29, 2019 05:22 PM IST -
May 08, 2019 11:52 AM IST Motilal Oswal is bullish on Sanofi India has recommended buy rating on the stock with a target price of Rs 6930 in its research report dated May 07, 2019.
-
May 07, 2019 03:35 PM IST The company had posted a net profit of Rs 82.5 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to the BSE.
-
May 07, 2019 02:56 PM IST -
Nov 01, 2018 11:04 AM IST -
Oct 31, 2018 06:07 PM IST The company had posted a net profit of Rs 116.3 crore for the corresponding period of the previous fiscal, Sanofi India said in a filing to BSE.
-
Oct 31, 2018 04:43 PM IST -
Aug 06, 2018 03:28 PM IST The drug offers patients diagnosed with multiple sclerosis the efficacy and convenience of once-a-day oral treatment.
-
Jun 06, 2018 11:56 AM IST Traders can buy the stock around in dips around Rs 5,040-5,050 with a stop loss below Rs 4,880 (closing) for the target of Rs 5,335.